Comparative efficacy of gestrinone and danazol in infertile women with endometriosis.

article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-08

Gestrinone and danazol demonstrated similar efficacy in improving symptoms and fertility in infertile women with endometriosis, but gestrinone offered a better side effect profile and ease of administration.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The relationship between endometriosis and infertility is observed frequently. Patients with both conditions require a conservative approach to their management. Since hormonal therapy is one of those approaches, we sought to compare the efficacy of Danazol and Gestrinone in 80 infertile patients (48 and 32, respectively). Therapy lasted 6 months in both treatment groups, and all patients studied had laboratory tests performed and were clinically evaluated and classified through laparoscopy before and after therapy. The improvement of symptoms and favorable follow-up were similar with both treatments. The reestablishment of menstrual patterns and fertility were also nearly alike in both groups. However, Gestrinone was associated with fewer secondary effects and is easier to administer than Danazol. We conclude that Gestrinone is a useful medication in the management of the infertile patient with endometriosis.

My notes (saved in your browser only)

Condition tags

mesh:D004414mesh:D004715endometriosisinfertility

MeSH descriptors

Danazol Endometriosis Gestrinone Infertility, Female Pelvic Neoplasms Adult Danazol Danazol Danazol Drug Tolerance Dyspareunia Dyspareunia Endometriosis Endometriosis Endometriosis Female Follow-Up Studies Gestrinone Gestrinone Gestrinone

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:39.448046+00:00
License: CC0 · commercial use OK